FindTrial
Sign In

Development of a Predictive Tool Incorporating Treatment Data for Long-term Prognosis in Clear Cell Adenocarcinoma of the Cervix: A Population-based Approach

Development of a Predictive Tool Incorporating Treatment Data for Long-term Prognosis in Clear Cell Adenocarcinoma of the Cervix: A Population-based Approach

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500097240
Enrollment
Unknown
Registered
2025-02-14
Start date
2024-12-01
Completion date
Unknown
Last updated
2025-02-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Clear Cell Adenocarcinoma of the Cervix

Interventions

Patients with clear cell adenocarcinoma of the cervi:None

Sponsors

The Second Affiliated Hospital of Fujian Medical University
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: (i) the International Classification of Diseases (ICD) code 0-3 morphology 8310/3; (ii) site record of ICD-O-3 encompassed cervix uteri; (iii) active follow-up to guarantee dependable patient status.

Exclusion criteria

Exclusion criteria: None

Design outcomes

Primary

MeasureTime frame
Overall survival;—

Countries

China

Contacts

Public ContactYanhong Wang

The Second Affiliated Hospital of Fujian Medical University

wyq47372@fjmu.edu.cn+86 186 5973 1867

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026